Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-03-2015 | Head and Neck

Survivin expression correlates with nodal metastasis in T1–T2 squamous cell carcinoma of the tongue

Authors: Murat Doğan, Sedat Çağlı, İmdat Yüce, Ali Bayram, Mehmet Akif Somdaş, Duran Karataş, Mehmet Celalettin Cihan, Fatih Yüksel, Ercihan Güney

Published in: European Archives of Oto-Rhino-Laryngology | Issue 3/2015

Abstract

In this study, the correlation between neck metastasis and recurrence was investigated by studying specimens of tongue squamous cell carcinoma patients immunohistochemical with survivin antibodies in the primary biopsy. A retrospective review was conducted at the Academic University Hospital. 46 patients who had squamous cell carcinoma of the tongue, who underwent various types of glossectomy and neck dissections between 1991 and 2008, were evaluated. The patient’s sex, TNM staging, differentiation and recurrence rates were analyzed. There were 20 T1 patients and 26 T2 patients; 27 of the patients were N0 and 19 had metastatic lymph nodes in the neck. Survivin antibodies were applied with streptavidin–biotin method to the sections that were prepared from the primary tumor biopsy specimens of the patients. The correlation between neck metastasis and recurrence and survivins’ immunohistochemical staining was analyzed with statistical methods. There were no significant differences between the patient’s age, sex, tumor’s T stage, tumor differentiation and survivin staining density. Survivin staining was positive in 15 (79 %) of 19 patients with neck metastasis, while it was positive in 16 (59 %) of 27 patients without neck metastasis. Eleven (79 %) of the 14 patients who had recurrence and all 6 patients who had neck recurrence only were stained by survivin. Expression of nuclear and cytoplasmic survivin can be a useful marker for predicting cervical lymph node metastasis in T1–T2 tumors in tongue SCC.

Johnson JT, Barnes EL, Myers EN, Schramm VL, Borochovitz D, Sigler BA (1981) The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol 107:725–729CrossRefPubMed

Dias FL, Kligerman J, Matos de Sa G, Arcuri RA, Freitas EQ, Farias T, Matos F, Lima RA (2001) Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 125:23–29CrossRefPubMed

Ho CM, Lam KH, Wei WI, Lau SK, Lam LK (1992) Occult lymph node metastasis in small oral tongue cancers. Head Neck 14:359–363CrossRefPubMed

Yamazaki H, Inoue T, Yoshida K, Tanaka E, Yoshioka Y, Nakamura H, Furukawa S, Shimizutani K (2004) Lymph node metastasis of early oral tongue cancer after interstitial radiotherapy. Int J Radiation Oncol Biol Phys 58:139–146CrossRef

Ferreira CG, Van der Valk P, Span SW, Ludwig I, Smit EF, Kruyt FAE, Pinedo HM, Van Tinteren H, Giaccone G (2001) Expression of X-linked inhibitor of apoptosis as a novel prognostic marker İn radically resected non-small cell lung cancer patients. Clin Cancer Res 7:2468–2474PubMed

Imoto I, Tsuda H, Hirasawa A, Miura M, Sakamoto M, Hirohashi S, Inazawa J (2002) Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy. Cancer Res 62:4860–4866PubMed

Liu SS, Tsang BK, Cheung ANY, Xue WC, Cheng DKL, Ng TY, Wong LC, Ngan HYS (2001) Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. Eur J Cancer 37:1104–1110CrossRefPubMed

Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M, Takano Y (2001) Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163:109–116CrossRefPubMed

Tanimoto T, Tsuda H, Imazeki N, Ohno Y, Imoto I, Inazawa J, Matsubara O (2005) Nuclear expression of cIAP–1, an apoptosis inhibiting protein, predicts lymph node metastasis and poor patient prognosis in head and neck squamous cell carcinomas. Cancer Lett 224:141–151CrossRefPubMed

10.

Imoto I, Yang ZQ, Pimkhaokham A, Tsuda H, Shimada Y, Imamura M, Ohki M, Inazawa J (2001) Identification of cIAP–1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res 61:6629–6634PubMed

11.

Liston P, Fong WG, Korneluk RG (2003) The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22:8568–8580CrossRefPubMed

12.

Salvesen GS, Duckett CS (2002) IAP proteins: blocking the road to death’s door. NatRevMol Cell Biol 3:401–410

13.

Reed JC, Doctor KS, Godzik A (2004) The domains of apoptosis: a genomics perspective. Sci STKE 22:91–99

14.

Rothe M, Pan MG, Henzel WJ, Ayers TM, Goeddel DV (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243–1252CrossRefPubMed

15.

Hu SM, Yang XL (2003) Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J BiolChem 278:10055–10060

16.

Li XM, Yang YL, Ashwell JD (2002) TNFRII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416:345–349CrossRefPubMed

17.

Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921CrossRefPubMed

18.

Lu CD, Altieri DC, Tanigawa N (1998) Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. CancerRes 58:1808–1812

19.

Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predict shorter survival rates in colorectal cancer. Cancer Res 58:5071–5074PubMed

20.

Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC (1998) Develop mentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 152:43–49PubMedCentralPubMed

21.

Leemans CR, Tiwari R, Nauta JJ, Snow GB (1991) Discontinuous vs in-continuity neck dissection of the oral cavity. Arch Otolaryngol Head Neck Surg 117(9):1003–1006CrossRefPubMed

22.

Pimenta Amaral TM, Da Silva Freire AR, Carvalho AL, Pinto CA, Kowalski LP (2004) Predictive factors of occult metastasis and pognosis of clinical stages I and II squamous cell carcinoma of the tongue and flor of the mouth. Oral Oncol 40:780–786CrossRefPubMed

23.

Ataula S, Grenman R, Laippala P, Syrjanen S (1996) Cancer of the tongue in patients younger than 40 years. Arch Otolaryngol. Head Neck Surg 122:1313–1319CrossRef

24.

Sanderson RJ, Ironside JA (2002) Squamous cell carcinoma of the head and neck. Br Med J 325:822–827CrossRef

25.

Okamoto M, Nishimine M, Kishi M, Kirita T, Sugimura M (2002) Prediction of delayed neck metastasis in patient stage I–II squamous cell carcinoma of the tongue. J Oral Pathol Med 31:227–233CrossRefPubMed

26.

Kaneko S, Yoshimura T, Ikemura K, Shirasuna K, Kusukawa J, Ohishi M et al (2002) Primary neck management among patients with cancer or the oral cavity without clinical nodal metastases: a decision and sensitivity analysis. Head Neck 24(6):582–590CrossRefPubMed

27.

Kırıta T, Okabe S, İzumo T, Sugimura M (1995) Risk factors of the postoperative local recurrence of tongue carcinoma. J Oral Maxillofac Surg 52:149–1543

28.

Gold KA, Kim ES (2009) Role of molecular markers and gene profiling in Head and Neck Cancers. Curr Opin Oncol 21:206–211CrossRefPubMed

29.

Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S et al (2008) Platinum based chemothrapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–1127CrossRefPubMed

30.

Marioni G, Bedogni A, Giacomelli L, Ferraro SM, Bertolin A, Facco E, Staffieri A, Marino F (2005) Survivin expression is significantly higher in pN + oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas. Acta Oto-Larnygologica 125:1218–1223CrossRef

31.

Span PN, Sweep FC, Wiegerinck ET, Tjan-Heijnen VC, Manders P, Beex LV, de Kok JB (2004) Survivin is an independent prognostic marker for risk stratification of breast cancer patients. ClinChem Nov;50(11):1986–1993

32.

Zhang Y, Huang D, Yu G (2005) Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas. Acta Oto-Laryngol 125:1345–1350CrossRef

33.

Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I (2002) Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma. Int J Mol Med 10:211–216PubMed

34.

Muzio LL, Staibano S, Pannone G, Mignogna MD, Mariggio A, Salvatore G, Chieffi P, Tramontano D, De Rosa G, Altieri DC (2001) Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. ExpMol Pathol 70:249–254

35.

Sohn DM, Kim SY, Baek MJ, Lim CW, Lee MH, Cho MS, Kim TY (2006) Expression of survivin and clinical correlation in patient with breast cancer. Biomed Pharmacother 60:289–292CrossRefPubMed

36.

Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri DC, Molina TJ (2000) Prognostic significance of survivin expression in diffuse large B cell lymphomas. Blood 96:1921–1925PubMed

37.

Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, Martin C, Font A, Barnadas A, Abad A (1999) A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J ClinOncol 17:2100–2104

38.

Samuel T, Okada K, Hyer M, Welsh K, Zapata JM, Reed JC (2005) cIAP1 localizes to the nuclear compartment and modulates the cell cycle. CancerRes 65:210–218

39.

Ribeiro DA, Kitakawa D, Domingues MA, Cabral LA, Marques ME, Salvadori DM (2007) Survivin and inducible nitricoxide synthase production during 4NQO-induced rat tongue carcinogenesis. Exp. And Mol. Pathol 83:131–137CrossRef

40.

Jinbu Y, Tsukinoki K, Myagi N, Senna T, Obi Y, Matsumoto K, Noguchi T, Kusama M (2006) Expression of Survivin in Oral Squamous Cell Carcinoma. Oral Med Pathol 11:41–44CrossRef

41.

Marioni G, Bedogni A, Giacomelli L, Ferraro SM (2005) Survivin expression is significantly higher in pN oral and oropharyngeal primary squamous cell carcinomas than in pNo carcinomas. Acta Otolaryngol 125:1218–1223CrossRefPubMed

42.

Qi S, Mogi S, Tsuda H, Tanaka Y, Kozaki K, Imoto I, Inazawa J, Hasegawa S, Omura K (2008) Expression of cIAP–1 correlates with nodal metastasis in squamous cell carcinoma of the tongue. Int J Oral Maxillofac Surg 37:1047–1053CrossRefPubMed

43.

Kim YH, Kim SM, Kim YK, Hong SP, Kim MJ, Myoung H (2010) Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma. J Oral Pathol Med 39:368–375PubMed

44.

Pickhard A, Gröber S, Haug A, Piontek G, Wirth M, Straßen U, Rudelius M, Reiter R (2014) Survivin and p-Akt as potential prognostic markers in squamous cell carcinoma of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol. doi:10.1016/j.oooo.2014.02.005 PubMed

Title: Survivin expression correlates with nodal metastasis in T1–T2 squamous cell carcinoma of the tongue
Authors: Murat Doğan
Sedat Çağlı
İmdat Yüce
Ali Bayram
Mehmet Akif Somdaş
Duran Karataş
Mehmet Celalettin Cihan
Fatih Yüksel
Ercihan Güney
Publication date: 01-03-2015
Publisher: Springer Berlin Heidelberg
Published in: European Archives of Oto-Rhino-Laryngology / Issue 3/2015
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-014-3009-3

At a glance: The STEP trials

Springer Medicine

Survivin expression correlates with nodal metastasis in T1–T2 squamous cell carcinoma of the tongue

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2015

The development and treatment of periprosthetic leakage after prosthetic voice restoration: a literature review and personal experience. Part II: conservative and surgical management

When is surgical therapy for head and neck malignant epithelial tumors not indicated?

Postoperative irradiation in patients with pT3-4N0 laryngeal cancer: results and prognostic factors

ADAM33 polymorphisms and susceptibility to allergic rhinitis: a meta-analysis

Mortality after tonsil surgery, a population study, covering eight years and 82,527 operations in Sweden

Long-term vocal outcomes of refined nerve-muscle pedicle flap implantation combined with arytenoid adduction